摘要
1文献来源Wu Y,Zhou Q,Chen M,et al.LBA43⁃GEMSTONE⁃301:A randomized,double⁃blind,placebo⁃controlled,phase 3 study of sugemalimab in patients with unresectable stageⅢnon⁃small cell lung cancer(NSCLC)who had not progressed after concurrent or sequential chemoradiotherapy(CRT)[J].Ann Oncol,2021,32(5S):S1283-S1346。
作者
朱正飞
谭佩欣
ZHU Zheng-fei;TAN Pei-xin(Department of Radiotherapy,Fudan University Shanghai Cancer Center,Shanghai 200032,China;不详)
出处
《循证医学》
2022年第1期4-7,共4页
The Journal of Evidence-Based Medicine
关键词
不可手术
Ⅲ期非小细胞肺癌
同步放化疗
序贯放化疗
免疫巩固治疗
unresectable
stageⅢnon⁃small cell lung cancer
concurrent chemoradiotherapy
sequential chemoradio⁃therapy
immunotherapy consolidation treatment
